Skip to content

Clinical trials

Migraine Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: Poland Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20101
20151
20163
20181
20195
20205
20217
20224
20231
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting7
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Amgen6
Teva Branded Pharmaceutical Products R&D, Inc.6
AbbVie5
H. Lundbeck A/S5
AstraZeneca1
Endo USA Inc., a Keenova Therapeutics Company1
Hospital Universitari Vall d'Hebron Research Institute1
Ipsen1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders37
Headache11
Hyperacusis3
Nausea3
Photophobia3
COVID-191
Headache Disorders1
Headache Disorders, Secondary1
Major Depressive Disorder1
Myalgia1

Trials

Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.